MERCK & CO. INC.(NYSE:MRK) stock News

MRK Latest News, Press Relases and Analysis

All

Press Releases

15 hours ago - By: Chartmill

Merck & Co. Inc. (NYSE:MRK) Excels in Caviar Cruise Quality Stock Screen

15 days ago - By: Chartmill

Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock

a day ago - By: Benzinga - Mentions: AZN

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs

a day ago - By: Bloomberg

AstraZeneca Pauses £200 Million Investment in UK Headquarters

2 days ago - By: Benzinga - Mentions: PFE PCVX

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

3 days ago - By: Merck & Co., Inc.

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease

3 days ago - By: Stocktwits - Mentions: AAPL NVDA GILD SLB

SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?

3 days ago - By: Stocktwits - Mentions: DUHP VFMF

Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50

3 days ago - By: Bloomberg

Merck Scraps Plans for £1 Billion London Hub in Fresh Blow to UK

3 days ago - By: Zacks Investment Research - Mentions: AZN JNJ PFE

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum

4 days ago - By: Zacks Investment Research - Mentions: BMY SMMT BNTX

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

4 days ago - By: Zacks Investment Research - Mentions: LLY AZN PFE

Will LLY's Oncology Portfolio Provide Key Diversification Benefits?

5 days ago - By: Investor's Business Daily - Mentions: PFE SMMT BNTX

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch

5 days ago - By: Zacks Investment Research - Mentions: JNJ PFE ABBV

J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?

6 days ago - By: Daiichi Sankyo

Ifinatamab Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial

10 days ago - By: The Motley Fool - Mentions: PFE

3 Things You Need to Know if You Buy Pfizer Today

10 days ago - By: Yahoo Finance - Mentions: BAC CI C F ...

US corporate debt market returns in force after market holiday

10 days ago - By: Zacks Investment Research - Mentions: REGN SNY AZN

MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline

10 days ago - By: Zacks Investment Research - Mentions: AZN JNJ PFE

J&J Gears Up for Some Key New Drug Approvals and Launches

11 days ago - By: The Motley Fool - Mentions: VZ T CVX TEVA ...

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

11 days ago - By: Zacks Investment Research - Mentions: BMY

Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?

11 days ago - By: Zacks Investment Research - Mentions: CORT

Can Korlym Drive Corcept's Growth Through the Rest of 2025?

11 days ago - By: Bloomberg - Mentions: VRNA

Merck Taps US Investment-Grade Bond Market for Verona Purchase

12 days ago - By: Stocktwits

Merck’s Investigational Drug Shows Reduction In Cholesterol In Late-stage Trial

12 days ago - By: Merck & Co., Inc.

Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study